BI-1358894

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameBI-1358894
Drug Alias NameBI-1358894
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionShort transient receptor potential channel 4 inhibitorsShort transient receptor potential channel 5 blockers
TargetsShort transient receptor potential channel 4Short transient receptor potential channel 5
Therapy Area/IndicationsStress Disorders, Post-TraumaticBorderline Personality DisorderDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[19] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-TraumaticBorderline Personality Disorder
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A